Abstract
PBC is a chronic progressive liver disease of unknown etiology. Several abnormalities found in PBC support the hypothesis that it may be considered an autoimmune disease. Despite the complex and interesting relationship that exists between autoimmune disorders and the complement system, very few reports on the level of the serum complement component in PBC have been published, and most of these comprised only a few patients or analyzed only a scant number of the complement components. In the present study, sera of 73 PBC patients were analyzed for the levels of 10 complement components. It was found that the levels of most of the serum complement components, including C1q, C2, C3, C5, C7, properdin and factor B were significantly elevated in patients with PBC in comparison to healthy controls. The level of C4 was slightly lower than that of the normal controls (p=0.019), while the levels of C6 and C8 were within the normal range. The number of PBC patients with serum levels of C4 and C6 <60% of normal pooled serum was higher than in the respective control groups (6/69 compared with 0/26 and 4/71 compared with 0/27, respectively). However, the difference was not statistically significant. Thus, our study shows alterations in the levels of most complement components in PBC, the reasons for which are discussed.
Similar content being viewed by others
References
Kaplan MM: Primary biliary cirrhosis. N Engl J Med 1987;16:521–528.
Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER: Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982;57:365–370.
Zurgil N, Konikoff F, Bakimer R, Slor H, Shoenfeld Y: Detection of anti-mitochondrial antibodies, characterization by ELISA and immunoblotting. Autoimmunity 1989;4:282–293.
Ruffati A, Arslan P, Floreani A et al: Nuclear membrane staining antinuclear antibody in patients with primary biliary cirrhosis. J Clin Immunol 1985;5:357–361.
Elta GH, Sepersky RA, Goldberg MJ et al: Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci 1983;28:971–975.
Lindgren S, Eriksson S: IgM in primary biliary cirrhosis: Physicochemical and complement activating properties. J Lab Clin Med 1982; 99:636–645.
Gupta RC, Dickson ER, McDuffie FC, Baggenstoss AH: Circulating IgG-complexes in primary biliary cirrhosis: A serial study in forty patients followed for two years. Clin Exp Immunol 1978;34:19–27.
Dienstang JL, Savarese AM, Cohen RB, Bhan AK: Circulating immune complexes in primary biliary cirrhosis. Clin Exp Immunol 1982;50:7–16.
Al-Aghbar MNA, Neuberger J, Williams R, Eddleston ALWF: Mononuclear cell complement receptor blockade in primary biliary cirrhosis. Gut 1985;26:20–25.
Mancini G, Carbonara AO, Heremans JF: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235–254.
Dowton SB, Colten HR: Acute phase reactants in inflammation and infection. Semin Hematol 1988; 25:84–90.
Howard PF, Hochberg MC, Bias WB, et al: Relationship between C4 null genes, HLA-D region and genetic susceptibility to systemic lupus erythematosus. Am J Med 1986;81:187–193.
Briggs DC, Welsh K, Scott Pereira R, Black CM: A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis. Arthritis Rheum 1986;29:1274–1277.
Shoenfeld Y, Isenberg DA: Complement deficiencies and autoimmunity; in The Mosaic of Autoimmunity. Amsterdam, Elsevier, 1989, pp 200–214.
Nydegger UE, Kazatchkine MD: Modulation by complement of immune complex processing in health and disease in man. Prog Allergy 1986;39:361–392.
Wands JR, Dienstag, JH, Bhan HK, et al: Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med 1978;298:233–237.
Potter BJ, Flias, E, Fayers PM, Jones EA: Profies of serum complement in patients with hepatobiliary disease. Digestion 1978;18:371–383.
Hauptmann G, Goetz J, Uring-Lambert B, Grosshans E: Component deficiency: the fourth component. Prog Allergy 1986;39:232–249.
Ross SC, Densen P: Complement deficiency states and infection. Medicine 1984;63:242–273.
Elison RT III, Horsburgh CR Jr, Curd J: Complement levels in patients with hepatic dysfunction. Dig Dis Sci 1990;35:231–235.
Potter BJ, Flias E, Thomas HC, Sherlock S: Complement metabolism in chronic liver disease: Catabolism of C1q in chronic active liver disease and primary biliary cirrhosis. Gastroenterology 1980;78:1034–1040.
Potter BJ, Elias E, Jones EA: Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J Lab Clin Med 1976;88:427–439.
Lindgren S, Laurell AB, Eriksson S: Complement components and activation in primary biliary cirrhosis. Hepatology 1984;4:9–14.
Macklon AF, Bird P, Bird G, James OFW: Complement profiles in early and late PBC. No evidence of C3 breakdown in vivo (abstract). Gastroenterology 1980;79:1036.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schlesinger, M., Benbassat, C. & Shoenfeld, Y. Complement profile in primary biliary cirrhosis. Immunol Res 11, 98–103 (1992). https://doi.org/10.1007/BF02918614
Issue Date:
DOI: https://doi.org/10.1007/BF02918614